How many episodes of hospital care might be prevented by widespread uptake of pneumococcal conjugate vaccine?

Archives of Disease in Childhood

Volumn 88, Issue 10, 2003, Pages 859-861

  McIntosh, E D G ^a,b  

^a PFIZER INC   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ANALYTIC METHOD; ARTICLE; BACTERIAL MENINGITIS; BLOOD GROUP TYPING; CALCULATION; CHILD HOSPITALIZATION; DIAGNOSTIC TEST; DRUG CONJUGATION; DRUG UPTAKE; HEALTH PROGRAM; HOSPITAL CARE; HUMAN; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MORBIDITY; NEWBORN INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEPTICEMIA; STATISTICS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; THEORY; UNITED KINGDOM;

AGE DISTRIBUTION; CHILD, PRESCHOOL; ENGLAND; HOSPITALIZATION; HUMANS; INFANT; MENINGITIS, PNEUMOCOCCAL; MORBIDITY; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; SEPSIS; VACCINES, CONJUGATE;

EID: 0141636341     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.88.10.859     Document Type: Article

References (16)

1. DoH. Getting ahead of the curve. Department of Health, 2001. http://www.doh.gov.uk/cmo/idstrategy/index.htm
2. McIntosh EDG, Booy R. Invasive pneumococcal disease in England and Wales: what is the true burden and what is the potential for prevention using 7 valent pneumococcal conjugate vaccine? Arch Dis Child 2002;86:403-6.
3. Moore MR, Gamble ML, Zell ER, et al. Deaths due to invasive Streptococcus pneumoniae, United States 1996-1998 (abstract 875). 39th Annual Meeting of the Infectious Diseases Society of America, 25-28 October 2001, San Francisco.
4. Turett GS, Blum S, Telzak EE. Recurrent pneumococcal bacteremia: risk factors and outcomes. Arch Intern Med 2001;161:2141-4.
5. Zhang Y, Isaacman DJ, Wadowsky RM, et al. Detection of Streptococcus pneumoniae in whole blood by PCR. J Clin Microbiol 1995;33:596-601.
6. Berkley JA, Mwangi IM, Ngetsa CJ, et al. Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa. Lancet 2001;357:1753-7.
7. Toikka P, Nikkari S, Ruuskanen O, et al. Pneumolysin PCR-based diagnosis of invasive pneumococcal infection in children. J Clin Microbiol 1999;37:633-7.
8. Dagan R, Shriker O, Hazan I, Leibovitz E, et al. Prospective study to determine clinical relevance of detection of pneumococcal DNA in sera of children by PCR. J Clin Microbiol 1998;36:669-73.
9. George RC, Melegaro A. Invasive pneumococcal infection in England and Wales 1999. CDR Weekly 2001;11(21).
10. Black S, Shinefield H, Fireman B, et al, and the North California Kaiser Permanente Vaccine Study Center Group. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000;19:187-95.
11. Black S, Shinefield PR, Ling S, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J 2002;21:810-15.
12. http://www.phls.org.uk/topics_az/vaccination/cover.htm.
13. Miller E, Waight P, Efstratiou A, et al. Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998. Acta Paediatr 2000;(suppl 435):11-16.
14. Sleeman K, Knox K, George R, et al. Invasive pneumococcal disease in England and Wales: vaccination implications. J Infect Dis 2001;183:239-46.
15. Finn A, Booy R, Moxon R, et al. Should the new pneumococcal vaccine be used in high-risk children? Arch Dis Child 2002;87:18-21.
16. Lee GM, Fleisher GR, Harper MB. Management of febrile children in the age of conjugate vaccine: a cost-effectiveness analysis. Pediatrics 2001;108:835-44.